Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer.
Wang J, Lamolinara A, Conti L, Giangrossi M, Cui L, Morelli MB, Amantini C, Falconi M, Bartolacci C, Andreani C, Orlando F, Provinciali M, Del Pizzo FD, Russo F, Belletti B, Riccardo F, Bolli E, Quaglino E, Cavallo F, Amici A, Iezzi M, Marchini C. Wang J, et al. Among authors: belletti b. Cancers (Basel). 2022 Aug 22;14(16):4054. doi: 10.3390/cancers14164054. Cancers (Basel). 2022. PMID: 36011047 Free PMC article.
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib.
Tilio M, Gambini V, Wang J, Garulli C, Kalogris C, Andreani C, Bartolacci C, Elexpuru Zabaleta M, Pietrella L, Hysi A, Iezzi M, Belletti B, Orlando F, Provinciali M, Galeazzi R, Marchini C, Amici A. Tilio M, et al. Among authors: belletti b. Cancer Lett. 2016 Oct 10;381(1):76-84. doi: 10.1016/j.canlet.2016.07.028. Epub 2016 Jul 27. Cancer Lett. 2016. PMID: 27475932
A novel 3'-tRNAGlu-derived fragment acts as a tumor suppressor in breast cancer by targeting nucleolin.
Falconi M, Giangrossi M, Zabaleta ME, Wang J, Gambini V, Tilio M, Bencardino D, Occhipinti S, Belletti B, Laudadio E, Galeazzi R, Marchini C, Amici A. Falconi M, et al. Among authors: belletti b. FASEB J. 2019 Dec;33(12):13228-13240. doi: 10.1096/fj.201900382RR. Epub 2019 Sep 27. FASEB J. 2019. PMID: 31560576
., Wang, J., Gambini, V., Tilio, M., Bencardino, D., Occhipinti, S., Belletti, B., Laudadio, E., Galeazzi, R., Marchini, C., Amici, A. A novel 3'-tRNA(Glu)-derived fragment acts as a tumor suppressor in breast cancer by targeting nucleolin....
., Wang, J., Gambini, V., Tilio, M., Bencardino, D., Occhipinti, S., Belletti, B., Laudadio, E., Galeazzi, R., Marchini, C., A …
Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer.
Citron F, Segatto I, Vinciguerra GLR, Musco L, Russo F, Mungo G, D'Andrea S, Mattevi MC, Perin T, Schiappacassi M, Massarut S, Marchini C, Amici A, Vecchione A, Baldassarre G, Belletti B. Citron F, et al. Among authors: belletti b. Cancer Res. 2020 Mar 1;80(5):1064-1077. doi: 10.1158/0008-5472.CAN-19-1793. Epub 2019 Dec 20. Cancer Res. 2020. PMID: 31862778
p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer.
Rampioni Vinciguerra GL, Dall'Acqua A, Segatto I, Mattevi MC, Russo F, Favero A, Cirombella R, Mungo G, Viotto D, Karimbayli J, Pesce M, Vecchione A, Belletti B, Baldassarre G. Rampioni Vinciguerra GL, et al. Among authors: belletti b. Cell Death Dis. 2021 Oct 15;12(10):951. doi: 10.1038/s41419-021-04241-2. Cell Death Dis. 2021. PMID: 34654798 Free PMC article.
Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice.
Favero A, Segatto I, Capuano A, Mattevi MC, Rampioni Vinciguerra GL, Musco L, D'Andrea S, Dall'Acqua A, Gava C, Perin T, Massarut S, Marchini C, Baldassarre G, Spessotto P, Belletti B. Favero A, et al. Among authors: belletti b. NPJ Breast Cancer. 2024 Jan 6;10(1):5. doi: 10.1038/s41523-023-00608-0. NPJ Breast Cancer. 2024. PMID: 38184660 Free PMC article.
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer.
Gerratana L, Basile D, Franzoni A, Allegri L, Viotto D, Corvaja C, Bortot L, Bertoli E, Buriolla S, Targato G, Da Ros L, Russo S, Bonotto M, Belletti B, Baldassarre G, Damante G, Puglisi F. Gerratana L, et al. Among authors: belletti b. Front Oncol. 2020 Sep 18;10:550185. doi: 10.3389/fonc.2020.550185. eCollection 2020. Front Oncol. 2020. PMID: 33072577 Free PMC article.
103 results